New York City, US
|Alma mater||Brandeis University (B.S. Biology, 1973)|
UC San Diego School of Medicine (M.D., 1977)
|Known for||Perispinal Etanercept|
Edward Tobinick M.D. is an American physician, inventor, and scientist, who invented the use of the drug etanercept for chronic neurological dysfunction after stroke and brain injury, with multiple issued U.S. and foreign patents, including U.S. patent 8,900,583.
On October 6, 2018, Greg Hunt MP, the Minister for Health (Australia), announced that his government was allocating funds specifically for the study of perispinal etanercept for the rehabilitation of stroke survivors in Australia.
- Singh, Anita (February 7, 2017). "Andrew Marr: how having a stroke changed my marriage for the better". The Telegraph. Retrieved November 17, 2018.
- "New hope for survivors of stroke and traumatic brain injury". Springer Select. October 31, 2012. Retrieved November 17, 2018.
- "Stroke drug trial set for Australia". SBS News. October 6, 2018. Retrieved November 17, 2018.
- Hunt MP, Greg (October 6, 2018). "$1 million to support the rehabilitation of stroke survivors". Australia Ministry of Health. Retrieved November 17, 2018.
|2009||Edward Tobinick||Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers. U.S. Patent 7,629,311”||US|
|2014||Edward Tobinick||Methods for treatment of brain injury using biologics. U.S. Patent 8,900,583||US|